NELSON SCIENTIFIC LABS LLC
Potomac, MD · Medtech · Private
CardioWatch multi-omics blood biomarker assay for predicting radiation-induced cardiovascular disease
nelsonscilabs.com →- Grants
- $3.7M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $570K
- 2 awards · Health and Human S, Defense
- #376 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Metabolomics Based Prediction of Delayed Effects of Acute Radiation Exposure | $579,155 | |
| Federal grant | Department of Health and Human Services · Phase I · Metabolomics Based Prediction of Delayed Effects of Acute Radiation Exposure | $286,527 | |
| Federal contract | Department of Health and Human Services · SBIR Linkage/de-duplication Tool | $225,013 | |
| Federal grant | Department of Health and Human Services · Phase II · CardioWatch: An Omics-Based Prediction Assay for Cardiac Late Effects ofAcute Radiation | $995,681 | |
| Federal grant | Department of Health and Human Services · Phase II · CardioWatch: An Omics-Based Prediction Assay for Cardiac Late Effects ofAcute Radiation | $989,322 | |
| Federal contract | Department of Defense · Metabolomics For Human Serum Analysis | $345,025 | |
| Federal grant | Department of Health and Human Services · Phase II · CardioWatch: An Omics-Based Prediction Assay for Cardiac Late Effects ofAcute Radiation | $660,437 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 373 | AO TECHNOLOGIES, LLC | $597K | — |
| 374 | HEMOSONICS | $576K | $25M |
| 375 | Maryland Development Center, LLC | $574K | — |
| 376 | NELSON SCIENTIFIC LABS LLC | $570K | — |
| 377 | Spectradyne LLC | $553K | — |
| 378 | Oxford Performance Materials, Inc. | $547K | $46M |
| 379 | PROMPT DIAGNOSTICS, INC. | $543K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.